Recent results showed that HC2® predicted residual/recurrent AIS or invasive Adenocarcinoma (AdCa) during the follow-up of conservatively treated women for AIS significantly better than cytology, whose predictive power did not reach statistical significance at any of the FU visits.
← all excerpts
HPV-DNA testing for cervical cancer precursors: from evidence to clinical practice.
1
—
—